| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated chemotherapy for poor prognosis germ cell tumours
|
Horwich, A.
|
|
1994
|
30 |
Supplement 1 |
p. 1607-1611
5 p.
|
artikel
|
| 2 |
Activity of docetaxel (Taxotere) in small cell lung cancer
|
Smyth, J.F.
|
|
1994
|
30 |
Supplement 1 |
p. 1058-1060
3 p.
|
artikel
|
| 3 |
Acute pain syndrome at tumour site in neoplastic patients treated with vinorelbine: Report of Unusual toxicity
|
Gebbia, V.
|
|
1994
|
30 |
Supplement 1 |
p. 889-
1 p.
|
artikel
|
| 4 |
Adhesion to type V collagen and cloning efficiency in agar of 8701-BC breast cancer cells
|
Luparello, C.
|
|
1994
|
30 |
Supplement 1 |
p. 1400-1401
2 p.
|
artikel
|
| 5 |
Adult Wilms' tumour: Review of 22 cases
|
Kattan, J.
|
|
1994
|
30 |
Supplement 1 |
p. 1778-1782
5 p.
|
artikel
|
| 6 |
Alterations of parenchymal α1-adrenergic receptors in human lung adenocarcinoma
|
Kond ratenko, T.
|
|
1994
|
30 |
Supplement 1 |
p. S34-
1 p.
|
artikel
|
| 7 |
Amonafide as first-line chemotherapy for metastatic breast cancer
|
Kornek, G
|
|
1994
|
30 |
Supplement 1 |
p. 398-400
3 p.
|
artikel
|
| 8 |
Aortic infusion (5-FU, MMC, CDDP) and stop-flow (MMC, ADM) for systemically pretreated and progressive FIGO III c and IV ovarian cancer
|
Gailhofer, S.
|
|
1994
|
30 |
Supplement 1 |
p. S41-
1 p.
|
artikel
|
| 9 |
A phase I–II study of N-(phosphonacetyl)-l-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancer
|
Jodrell, D.I
|
|
1994
|
30 |
Supplement 1 |
p. 950-954
5 p.
|
artikel
|
| 10 |
A phase I II study of the intralesional injection of ricin-monoclonal antibody conjugates in patients with hepatic metastases
|
Zalcberg, J.R
|
|
1994
|
30 |
Supplement 1 |
p. 1227-1231
5 p.
|
artikel
|
| 11 |
A phase II study of high-dose hydroxyurea and dacarbazine (DTIC) in the treatment of metastatic malignant melanoma
|
Philip, P.A.
|
|
1994
|
30 |
Supplement 1 |
p. 1027-1029
3 p.
|
artikel
|
| 12 |
Appraisal of a model for prediction of prognosis in advanced colorectal cancer
|
Graf, W.
|
|
1994
|
30 |
Supplement 1 |
p. 453-457
5 p.
|
artikel
|
| 13 |
A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapy
|
Olver, I.N.
|
|
1994
|
30 |
Supplement 1 |
p. 426-429
4 p.
|
artikel
|
| 14 |
A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer
|
Eguchi, Kenji
|
|
1994
|
30 |
Supplement 1 |
p. 188-194
7 p.
|
artikel
|
| 15 |
A survey of the management of breast cancer in England and Wales
|
Harries, S.A.
|
|
1994
|
30 |
Supplement 1 |
p. S21-
1 p.
|
artikel
|
| 16 |
Brain metastases from breast cancer: Predictive factors for long-time survival
|
Nieder, C.
|
|
1994
|
30 |
Supplement 1 |
p. S23-
1 p.
|
artikel
|
| 17 |
Breast cancer in less than 36 years of age patients. Clinique sainte-catherine experience
|
Vuillemin, E.
|
|
1994
|
30 |
Supplement 1 |
p. S25-
1 p.
|
artikel
|
| 18 |
Cancer surveys — Volume 18: Breast cancer
|
|
|
1994
|
30 |
Supplement 1 |
p. 1203-1204
2 p.
|
artikel
|
| 19 |
Carboplatin and α-2b interferon intraperitoneal combination as first-line treatment of minimal residual ovarian cancer. A pilot study
|
Frasci, G
|
|
1994
|
30 |
Supplement 1 |
p. 946-950
5 p.
|
artikel
|
| 20 |
Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: Preliminary report of a French multicentre phase II trial
|
Rivière, A.
|
|
1994
|
30 |
Supplement 1 |
p. 587-590
4 p.
|
artikel
|
| 21 |
Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patients
|
Maltoni, M.
|
|
1994
|
30 |
Supplement 1 |
p. 764-766
3 p.
|
artikel
|
| 22 |
Clinical utilisation of human haematopoietic progenitors elicited in peripheral blood by recombinant human granulocyte colony-stimulating factor (rHuG-CSF)
|
Bregni, Marco
|
|
1994
|
30 |
Supplement 1 |
p. 235-238
4 p.
|
artikel
|
| 23 |
Clones of a human ovarian cancer cell lines expressing wild-type or mutated as a model for studying new anticancer agents
|
Broggini, M.
|
|
1994
|
30 |
Supplement 1 |
p. S7-
1 p.
|
artikel
|
| 24 |
Colony-stimulating factor-producing tumours: Production of granulocyte colony-stimulating factor and interleukin-6 is secondary to interleukin-1 production
|
Tsuyuoka, R.
|
|
1994
|
30 |
Supplement 1 |
p. 2130-2136
7 p.
|
artikel
|
| 25 |
Comparison of chemotherapy with or without medroxyprogesterone acetate for advanced or recurrent breast cancer
|
Tominaga, T
|
|
1994
|
30 |
Supplement 1 |
p. 959-964
6 p.
|
artikel
|
| 26 |
Constitutive secretion of bioactive transforming growth factor β 1 by small cell lung cancer cell lines
|
Fischer, J.R.
|
|
1994
|
30 |
Supplement 1 |
p. 2125-2129
5 p.
|
artikel
|
| 27 |
C-raf-1 proto-oncogene expression relates to radiosensitivity rather than radioresistance
|
Warenius, Hilmar M.
|
|
1994
|
30 |
Supplement 1 |
p. 369-375
7 p.
|
artikel
|
| 28 |
CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation
|
Rastel, D.
|
|
1994
|
30 |
Supplement 1 |
p. 601-606
6 p.
|
artikel
|
| 29 |
Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients
|
Hill, B.T.
|
|
1994
|
30 |
Supplement 1 |
p. 832-837
6 p.
|
artikel
|
| 30 |
Diet in the aetiology of cancer editorial comment
|
Boyle, Peter
|
|
1994
|
30 |
Supplement 1 |
p. 133-
1 p.
|
artikel
|
| 31 |
Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials group
|
Aamdal, S.
|
|
1994
|
30 |
Supplement 1 |
p. 1061-1064
4 p.
|
artikel
|
| 32 |
Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC early clinical trials group
|
Bruntsch, U.
|
|
1994
|
30 |
Supplement 1 |
p. 1064-1067
4 p.
|
artikel
|
| 33 |
Dolichol as a tumour marker in ovarian cancer control
|
Kuznetsovs, S.
|
|
1994
|
30 |
Supplement 1 |
p. S42-
1 p.
|
artikel
|
| 34 |
Dose-dependent dissociation of effects of 5aza CdR on growth and differentiation of the human leukemic cell line U-937
|
Attadia, V.
|
|
1994
|
30 |
Supplement 1 |
p. S36-
1 p.
|
artikel
|
| 35 |
Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-α2b and folinic acid. The “GISCAD” experience
|
Labianca, R.
|
|
1994
|
30 |
Supplement 1 |
p. 1611-1616
6 p.
|
artikel
|
| 36 |
Effect of inhalant fungotherapy on lewis lung carcinoma spreading in mice
|
Kuznetsovs, S.
|
|
1994
|
30 |
Supplement 1 |
p. S11-
1 p.
|
artikel
|
| 37 |
Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated mice
|
Treskes, Marco
|
|
1994
|
30 |
Supplement 1 |
p. 183-187
5 p.
|
artikel
|
| 38 |
Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy
|
Sorbe, B.
|
|
1994
|
30 |
Supplement 1 |
p. 629-634
6 p.
|
artikel
|
| 39 |
Efficacy and tolerance of oral dipyrone versus oral morphine for cancer pain
|
Rodríguez, M.
|
|
1994
|
30 |
Supplement 1 |
p. 584-587
4 p.
|
artikel
|
| 40 |
Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancer
|
Dowsett, M.
|
|
1994
|
30 |
Supplement 1 |
p. 1453-1458
6 p.
|
artikel
|
| 41 |
Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer
|
Gadducci, A.
|
|
1994
|
30 |
Supplement 1 |
p. 1432-1435
4 p.
|
artikel
|
| 42 |
Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group
|
Bajetta, E.
|
|
1994
|
30 |
Supplement 1 |
p. 596-600
5 p.
|
artikel
|
| 43 |
European Cancer Centre/NDDO postgrduate course on basic and current topics in anticancer drug development
|
|
|
1994
|
30 |
Supplement 1 |
p. 1039-
1 p.
|
artikel
|
| 44 |
Evaluation of prognostic factors with respect to survival of colorectal cancer patients
|
Ozyilkan, O.
|
|
1994
|
30 |
Supplement 1 |
p. S30-
1 p.
|
artikel
|
| 45 |
EWS/FLI-1 rearrangement in small round cell sarcomas of bone and soft tissue detected by reverse transcriptase polymerase chain reaction amplification
|
Pellin, A
|
|
1994
|
30 |
Supplement 1 |
p. 827-831
5 p.
|
artikel
|
| 46 |
Expression of functional very late Antigen-α 1, -α 2, -α 3 and -α 6 integrins on Ewing's sarcoma and primitive peripheral neuroectodermal tumour cells and modulation by interferon-γ and tumour necrosis factor-α
|
van Valen, F.
|
|
1994
|
30 |
Supplement 1 |
p. 2119-2125
7 p.
|
artikel
|
| 47 |
Expression of π-glutathione S-transferase gene (GSTP1) in gastric cancer: Lack of correlation with resistance against cis-diamminedichloroplatinum (II)
|
Kodera, Y.
|
|
1994
|
30 |
Supplement 1 |
p. 2158-2162
5 p.
|
artikel
|
| 48 |
Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: Frequency and prognostic significance
|
Passlick, B.
|
|
1994
|
30 |
Supplement 1 |
p. 376-381
6 p.
|
artikel
|
| 49 |
Expression of p21 ras protein as a prognostic factor in papillary thyroid cancer
|
Basolo, Fulvio
|
|
1994
|
30 |
Supplement 1 |
p. 171-174
4 p.
|
artikel
|
| 50 |
Expression of sicam-1 in urine and serum of bladder cancer patients: A useful marker?
|
Rohde, D.
|
|
1994
|
30 |
Supplement 1 |
p. S12-
1 p.
|
artikel
|
| 51 |
Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia
|
Robertson, N.
|
|
1994
|
30 |
Supplement 1 |
p. 1013-1019
7 p.
|
artikel
|
| 52 |
Favourable survival outcome in patients with SCLC treated by sequential intensive chemotherapy and high dose chest irradiation
|
Chella, A.
|
|
1994
|
30 |
Supplement 1 |
p. S33-
1 p.
|
artikel
|
| 53 |
Fecal high butyrate production of clinical relevance with plantago ovata seeds (POS)
|
Jahnig,
|
|
1994
|
30 |
Supplement 1 |
p. S29-
1 p.
|
artikel
|
| 54 |
Five-days administration of cisplatin and vepesid in inoperable non small cells lung cancer (NSCLC)
|
Sogno, G.
|
|
1994
|
30 |
Supplement 1 |
p. S35-
1 p.
|
artikel
|
| 55 |
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus
|
Stahl, Michael
|
|
1994
|
30 |
Supplement 1 |
p. 325-328
4 p.
|
artikel
|
| 56 |
Growth inhibition of xenotransplanted human carcinomas by a monoclonal antibody directed against the epidermal growth factor receptor
|
Schnürch, H.-G
|
|
1994
|
30 |
Supplement 1 |
p. 491-496
6 p.
|
artikel
|
| 57 |
Haematological toxicity of radiotherapy following high-dose chemotherapy and autologous bone marrow transplantation in patients with recurrent Hodgkin's disease
|
Price, A
|
|
1994
|
30 |
Supplement 1 |
p. 903-907
5 p.
|
artikel
|
| 58 |
High cell proliferation activity determined by DNA flow cytometry predicts poor prognosis after relapse in prostate cancer
|
Visakorpi, T.
|
|
1994
|
30 |
Supplement 1 |
p. 129-130
2 p.
|
artikel
|
| 59 |
High dose level radiation therapy for local tumour control in esthesioneuroblastoma
|
Guedea, F.
|
|
1994
|
30 |
Supplement 1 |
p. 1757-1760
4 p.
|
artikel
|
| 60 |
Human leucocyte interferon-α therapy can induce a second response in treatment of thrombocytosis in patients with neutralising antibodies to recombinant interferon-α2a
|
Merup, M.
|
|
1994
|
30 |
Supplement 1 |
p. 1729-1730
2 p.
|
artikel
|
| 61 |
Human tumour bank in Croatia: a possible model for a small bank as part of the future European tumour bank network
|
Spaventi, Radan
|
|
1994
|
30 |
Supplement 1 |
p. 419-
1 p.
|
artikel
|
| 62 |
III. Immunology of UV-irradiated skin
|
Krutmann, J.
|
|
1994
|
30 |
Supplement 1 |
p. 554-555
2 p.
|
artikel
|
| 63 |
Immunohistochemical evaluation of P53-gene expression in patients with non-Hodgkin's lymphoma: Correlation to histological subtype and EBV-status
|
Houmand, A.
|
|
1994
|
30 |
Supplement 1 |
p. S39-
1 p.
|
artikel
|
| 64 |
Immunological response to intrathecal and systemic treatment with ganglioside antibody R-24 in patients with malignant melanoma
|
Dippold, Wolfgang
|
|
1994
|
30 |
Supplement 1 |
p. 137-144
8 p.
|
artikel
|
| 65 |
Immunoscintigraphy of bone sarcomas—results in 5 patients
|
Bruland, Ø.S.
|
|
1994
|
30 |
Supplement 1 |
p. 1484-1489
6 p.
|
artikel
|
| 66 |
Immunoscintigraphy using 111In-labelled F(ab′)2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma
|
Vuillez, J.-P.
|
|
1994
|
30 |
Supplement 1 |
p. 1089-1092
4 p.
|
artikel
|
| 67 |
Increased arterial inflow demonstrated by Doppler ultrasound in arm swelling following breast cancer treatment
|
Svensson, W.E.
|
|
1994
|
30 |
Supplement 1 |
p. 661-664
4 p.
|
artikel
|
| 68 |
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine
|
Pronk, L.C.
|
|
1994
|
30 |
Supplement 1 |
p. 1019-1022
4 p.
|
artikel
|
| 69 |
Induction of tumour cell lysis by a bispecific antibody recognising epidermal growth factor receptor (EGFR) and CD3
|
Knuth, A.
|
|
1994
|
30 |
Supplement 1 |
p. 1103-1107
5 p.
|
artikel
|
| 70 |
Influence of TGF β1 and chemotherapy on cytokine secretion in SCLC
|
Fischer, J.R.
|
|
1994
|
30 |
Supplement 1 |
p. S11-
1 p.
|
artikel
|
| 71 |
Inhibiting intracellular signalling as a strategy for cancer chemoprevention
|
Powis, G
|
|
1994
|
30 |
Supplement 1 |
p. 1138-1144
7 p.
|
artikel
|
| 72 |
Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines
|
Berkovic, D.
|
|
1994
|
30 |
Supplement 1 |
p. 509-515
7 p.
|
artikel
|
| 73 |
Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes
|
de Graaf, H.
|
|
1994
|
30 |
Supplement 1 |
p. 150-153
4 p.
|
artikel
|
| 74 |
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer
|
Fountzilas, G.
|
|
1994
|
30 |
Supplement 1 |
p. 965-969
5 p.
|
artikel
|
| 75 |
Interferons combined with chemotherapy in the treatment of stage III-IV non-small cell lung cancer—a randomised study
|
Halme, M.
|
|
1994
|
30 |
Supplement 1 |
p. 11-15
5 p.
|
artikel
|
| 76 |
Inter-relationships between single carbon units' metabolism and resting energy expenditure in weight-losing patients with small cell lung cancer. Effects of methionine supply and chemotherapy
|
Sengeløv, H.
|
|
1994
|
30 |
Supplement 1 |
p. 1616-1620
5 p.
|
artikel
|
| 77 |
Introduction
|
Cascinelli, N.
|
|
1994
|
30 |
Supplement 1 |
p. 549-550
2 p.
|
artikel
|
| 78 |
In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells
|
Villa, R.
|
|
1994
|
30 |
Supplement 1 |
p. 1534-1540
7 p.
|
artikel
|
| 79 |
Local injection of OK-432/Fibrinogen gel into head and neck carcinomas
|
Kumazawa, H.
|
|
1994
|
30 |
Supplement 1 |
p. 1741-1744
4 p.
|
artikel
|
| 80 |
Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: Reduction in local treatment failure
|
Goldberg, P.A.
|
|
1994
|
30 |
Supplement 1 |
p. 1602-1606
5 p.
|
artikel
|
| 81 |
Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary
|
Culine, S.
|
|
1994
|
30 |
Supplement 1 |
p. 1239-1244
6 p.
|
artikel
|
| 82 |
Low-dose γ-interferon therapy is ineffective in renal cell carcinoma patients with large tumour burden
|
Aulitzky, W.E
|
|
1994
|
30 |
Supplement 1 |
p. 940-945
6 p.
|
artikel
|
| 83 |
Management of bowel obstruction in patients with advanced ovarian cancer
|
Zoetmulder, F.A.N.
|
|
1994
|
30 |
Supplement 1 |
p. 1625-1628
4 p.
|
artikel
|
| 84 |
Management of breast cancer in the elderly
|
Martin, L.M.
|
|
1994
|
30 |
Supplement 1 |
p. 590-596
7 p.
|
artikel
|
| 85 |
MDM2 gene amplification in human breast cancer
|
Quesnel, B.
|
|
1994
|
30 |
Supplement 1 |
p. 982-984
3 p.
|
artikel
|
| 86 |
Medical therapy of malignant nerve pain. A randomised double-blind explanatory trial with naproxen versus slow-release morphine
|
Dellemijn, P.L.I
|
|
1994
|
30 |
Supplement 1 |
p. 1244-1250
7 p.
|
artikel
|
| 87 |
Medullary carcinoma of the breast, prognostic importance of characteristic histopathological features evaluated in a multivariate cox analysis
|
Pedersen, L.
|
|
1994
|
30 |
Supplement 1 |
p. 1792-1797
6 p.
|
artikel
|
| 88 |
Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction—Single strand conformational polymorphism analysis and possible consequences in cancer cells
|
Touitou, Isabelle
|
|
1994
|
30 |
Supplement 1 |
p. 390-394
5 p.
|
artikel
|
| 89 |
Mitoxantrone and 5-fluorouracil modulated by the pure (6S) stereoisomer of leucovorin as second-line chemotherapy for advanced breast cancer
|
Pronzato, P.
|
|
1994
|
30 |
Supplement 1 |
p. 1593-1594
2 p.
|
artikel
|
| 90 |
Mitoxantrone, 5-fluorouracil and levo-leucovorin as salvage treatment in advanced breast cancer patients
|
Mammoliti, Serafina
|
|
1994
|
30 |
Supplement 1 |
p. 248-249
2 p.
|
artikel
|
| 91 |
Multimodal treatment of locally advanced transitional cell bladder carcinoma in elderly patients
|
Veronesi, A
|
|
1994
|
30 |
Supplement 1 |
p. 918-920
3 p.
|
artikel
|
| 92 |
Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease
|
Clerici, M.
|
|
1994
|
30 |
Supplement 1 |
p. 1464-1470
7 p.
|
artikel
|
| 93 |
Multiple endocrine neoplasia type 1 (MEN1)
|
Pang, J.T.
|
|
1994
|
30 |
Supplement 1 |
p. 1961-1968
8 p.
|
artikel
|
| 94 |
Mutational analysis of the first 14 exons of the adenomatous polyposis coli (APC) gene
|
Dobbie, Z.
|
|
1994
|
30 |
Supplement 1 |
p. 1709-1713
5 p.
|
artikel
|
| 95 |
Mutation analysis of RASK and the ‘FLR exon’ of NF1 in sporadic ovarian carcinoma
|
Foulkes, W.D.
|
|
1994
|
30 |
Supplement 1 |
p. 528-530
3 p.
|
artikel
|
| 96 |
Mutations in two sets of bladder cancer patients
|
Kannio, A.
|
|
1994
|
30 |
Supplement 1 |
p. S3-
1 p.
|
artikel
|
| 97 |
Neoadiuvant chemotherapy with epihin inflammatory breast cancer
|
Butera, A.
|
|
1994
|
30 |
Supplement 1 |
p. S18-
1 p.
|
artikel
|
| 98 |
Neoadjuvant chemotherapy in locally advanced gastric carcinoma—a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum
|
Rougier, Ph
|
|
1994
|
30 |
Supplement 1 |
p. 1269-1275
7 p.
|
artikel
|
| 99 |
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6
|
Scholl, S.M.
|
|
1994
|
30 |
Supplement 1 |
p. 645-652
8 p.
|
artikel
|
| 100 |
Neurofibromatosis type 1
|
Colman, S.D.
|
|
1994
|
30 |
Supplement 1 |
p. 1974-1981
8 p.
|
artikel
|
| 101 |
Neurological and cognitive impairment in long-term survivors of small cell lung cancer
|
Cull, A.
|
|
1994
|
30 |
Supplement 1 |
p. 1067-1074
8 p.
|
artikel
|
| 102 |
N-myc gene copy number in neuroblastoma cell lines and resistance to experimental treatment
|
Livingstone, A
|
|
1994
|
30 |
Supplement 1 |
p. 382-389
8 p.
|
artikel
|
| 103 |
Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate- or high-grade histology
|
Bessell, E.M.
|
|
1994
|
30 |
Supplement 1 |
p. 1337-1341
5 p.
|
artikel
|
| 104 |
Paclitaxel-induced cytotoxicity—the effects of cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of the permeability glycoprotein
|
Fjällskog, M.-L.
|
|
1994
|
30 |
Supplement 1 |
p. 687-690
4 p.
|
artikel
|
| 105 |
Paclitaxel (Taxol) induces cumulative mild neurotoxicity
|
van Gerven, J.M.A
|
|
1994
|
30 |
Supplement 1 |
p. 1074-1077
4 p.
|
artikel
|
| 106 |
Palliation of malignant intestinal obstruction using octreotide
|
Khoo, D.
|
|
1994
|
30 |
Supplement 1 |
p. 28-30
3 p.
|
artikel
|
| 107 |
Patterns and temporal trends in the incidence of malignant disease in children: II. Solid tumours of childhood
|
Blair, V.
|
|
1994
|
30 |
Supplement 1 |
p. 1498-1511
14 p.
|
artikel
|
| 108 |
p53 gene mutations in women with breast cancer and a previous history of benign breast disease
|
Seth, A.
|
|
1994
|
30 |
Supplement 1 |
p. 808-812
5 p.
|
artikel
|
| 109 |
Pharmacokinetics of folinic acid and 5-methyltetrahydrofolic metabolite after repeated oral administration of calcium folinate following methotrexate treatment
|
Tubiana-Mathieu, N.
|
|
1994
|
30 |
Supplement 1 |
p. 1281-1284
4 p.
|
artikel
|
| 110 |
Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma
|
Veenhof, C.H.N.
|
|
1994
|
30 |
Supplement 1 |
p. 697-698
2 p.
|
artikel
|
| 111 |
Phase II study of mitomycin C plus 5-fluorouracil in patients with refractory ovarian cancer
|
Peláez, I.
|
|
1994
|
30 |
Supplement 1 |
p. 1206-1207
2 p.
|
artikel
|
| 112 |
Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: Report from the Japan Clinical Oncology Group (JCOG)
|
Ohtsu, A.
|
|
1994
|
30 |
Supplement 1 |
p. 2091-2093
3 p.
|
artikel
|
| 113 |
Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy—a phase II study of the EORTC gynaecological cancer cooperative group
|
Guastalla, J.P.
|
|
1994
|
30 |
Supplement 1 |
p. 45-49
5 p.
|
artikel
|
| 114 |
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma
|
Rosso, R
|
|
1994
|
30 |
Supplement 1 |
p. 338-343
6 p.
|
artikel
|
| 115 |
Phase II trial of high-dose epirubicin and cyclophosphamide in advanced breast cancer
|
Scinto, A.F
|
|
1994
|
30 |
Supplement 1 |
p. 1285-1288
4 p.
|
artikel
|
| 116 |
Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study
|
Schiller, Joan H.
|
|
1994
|
30 |
Supplement 1 |
p. 158-161
4 p.
|
artikel
|
| 117 |
Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer
|
Casslén, B
|
|
1994
|
30 |
Supplement 1 |
p. 1302-1309
8 p.
|
artikel
|
| 118 |
Predictors of residual mass histology following chemotherapy for metastatic non-seminomatous testicular cancer: a quantitative overview of 996 resections
|
Steyerberg, E.W.
|
|
1994
|
30 |
Supplement 1 |
p. 1231-1239
9 p.
|
artikel
|
| 119 |
Prenatal factors may influence predisposition to breast cancer
|
Anbazhagan, R.
|
|
1994
|
30 |
Supplement 1 |
p. 1-3
3 p.
|
artikel
|
| 120 |
Production of monoclonal antibodies recognising the peptide core of MUC2 intestinal mucin
|
Durrant, L.G
|
|
1994
|
30 |
Supplement 1 |
p. 355-363
9 p.
|
artikel
|
| 121 |
Prognosis of breast cancer in males: an analysis of 170 cases
|
Salvadori, B.
|
|
1994
|
30 |
Supplement 1 |
p. 930-935
6 p.
|
artikel
|
| 122 |
Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-α
|
Fosså, S.D.
|
|
1994
|
30 |
Supplement 1 |
p. 1310-1314
5 p.
|
artikel
|
| 123 |
Prognostic significance of pS2 protein expression in pulmonary adenocarcinoma
|
Higashiyama, M.
|
|
1994
|
30 |
Supplement 1 |
p. 792-797
6 p.
|
artikel
|
| 124 |
Prognostic value of a breast cancer-associated glycoprotein detected by monoclonal antibody LU-BCRU-G7
|
Rye, P.D
|
|
1994
|
30 |
Supplement 1 |
p. 1007-1012
6 p.
|
artikel
|
| 125 |
Relation of early photofrin® uptake to photodynamically induced phototoxicity and changes of cell volume in different cell lines
|
Leunig, A.
|
|
1994
|
30 |
Supplement 1 |
p. 78-83
6 p.
|
artikel
|
| 126 |
Relationships between tamoxifen binding proteins in primary breast cancer biopsies
|
Marsigliante, S.
|
|
1994
|
30 |
Supplement 1 |
p. 1694-1700
7 p.
|
artikel
|
| 127 |
Resident macrophages do not require dual signal stimulation for tumour cell lysis
|
Duggan, S.
|
|
1994
|
30 |
Supplement 1 |
p. S10-
1 p.
|
artikel
|
| 128 |
Response to oncologic epidemiological questions in under graduate medical students
|
Millán, J.
|
|
1994
|
30 |
Supplement 1 |
p. S14-
1 p.
|
artikel
|
| 129 |
Response to second-line weekly cisplatin chemotherapy in ovarian cancer previously treated with a cisplatin- or carboplatin-based regimen
|
Bolis, G.
|
|
1994
|
30 |
Supplement 1 |
p. 1764-1768
5 p.
|
artikel
|
| 130 |
Screening for anxiety and depression in cancer patients: the effects of disease and treatment
|
Ibbotson, T.
|
|
1994
|
30 |
Supplement 1 |
p. 37-40
4 p.
|
artikel
|
| 131 |
Second European Conference on medicines research: perspectives in clinical trials
|
|
|
1994
|
30 |
Supplement 1 |
p. 1727-
1 p.
|
artikel
|
| 132 |
Second-line treatment with ifosfamide and carboplatin in patients with ovarian carcinoma relapsing after treatment with carboplatin
|
Dobbs, Stephen P.
|
|
1994
|
30 |
Supplement 1 |
p. 30-33
4 p.
|
artikel
|
| 133 |
Serum concentrations of cytokines in patients with Hodgkin's disease
|
Blay, Jean-Yves
|
|
1994
|
30 |
Supplement 1 |
p. 321-324
4 p.
|
artikel
|
| 134 |
Serum p53 auto-antibodies: Incidence in familial breast cancer
|
Green, J.A.
|
|
1994
|
30 |
Supplement 1 |
p. 580-584
5 p.
|
artikel
|
| 135 |
Sex hormone levels in postmenopausal women with advanced metastatic breast cancer treated with CGS 169 49A
|
Svenstrup, B.
|
|
1994
|
30 |
Supplement 1 |
p. 1254-1258
5 p.
|
artikel
|
| 136 |
Soluble intercellular adhesion molecule—1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts
|
Giavazzi, R.
|
|
1994
|
30 |
Supplement 1 |
p. 1865-1870
6 p.
|
artikel
|
| 137 |
Somatostatin receptor expression in lung cancer
|
O'Byrne, K.J.
|
|
1994
|
30 |
Supplement 1 |
p. 1682-1687
6 p.
|
artikel
|
| 138 |
Subsequent primary cancers following bladder cancer
|
Salminen, E.
|
|
1994
|
30 |
Supplement 1 |
p. 303-307
5 p.
|
artikel
|
| 139 |
Suramin inhibits growth and transforming growth factor-β1 (TGF-β1) binding in osteosarcoma cell lines
|
Kloen, P.
|
|
1994
|
30 |
Supplement 1 |
p. 678-682
5 p.
|
artikel
|
| 140 |
Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapy
|
Rajan, B.
|
|
1994
|
30 |
Supplement 1 |
p. 1809-1815
7 p.
|
artikel
|
| 141 |
Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients
|
Helweg-Larsen, Susanne
|
|
1994
|
30 |
Supplement 1 |
p. 396-398
3 p.
|
artikel
|
| 142 |
Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: Immunolocalisation, pharmacokinetics and immune response
|
Kalofonos, H.P.
|
|
1994
|
30 |
Supplement 1 |
p. 1842-1850
9 p.
|
artikel
|
| 143 |
The effect of clodronate on bone in metastatic prostate cancer. Histomorphometric report of a double-blind randomised placebo-controlled study
|
Taube, T.
|
|
1994
|
30 |
Supplement 1 |
p. 751-758
8 p.
|
artikel
|
| 144 |
The effect of endocrine therapy on the levels of oestrogen and progesterone receptor and transforming growth factor-β1 in metastatic human breast cancer: an immunocytochemical study
|
Murray, P.A.
|
|
1994
|
30 |
Supplement 1 |
p. 1218-1222
5 p.
|
artikel
|
| 145 |
The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials
|
Bergman, B.
|
|
1994
|
30 |
Supplement 1 |
p. 635-642
8 p.
|
artikel
|
| 146 |
The importance of dose scheduling with mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer
|
Jolivet, J.
|
|
1994
|
30 |
Supplement 1 |
p. 626-628
3 p.
|
artikel
|
| 147 |
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress
|
Portenoy, R.K.
|
|
1994
|
30 |
Supplement 1 |
p. 1326-1336
11 p.
|
artikel
|
| 148 |
The Optimal Dose of Glycosylated Recombinant Human Granulocyte Colony Stimulating Factor for Use in Clinical Practice: A Review
|
Marty, M.
|
|
|
30 |
Supplement 1 |
p. S20-S25
|
artikel
|
| 149 |
The relative roles of vitronectin receptor, E-selectin and α 4 β 1 in cancer cell adhesion to interleukin-1-treated endothelial cells
|
Lafrenie, R.M.
|
|
1994
|
30 |
Supplement 1 |
p. 2151-2158
8 p.
|
artikel
|
| 150 |
The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin
|
Lopez, R.Lopez
|
|
1994
|
30 |
Supplement 1 |
p. 1545-1549
5 p.
|
artikel
|
| 151 |
20th International Congress on Breast Cancer Research
|
|
|
1994
|
30 |
Supplement 1 |
p. 715-716
2 p.
|
artikel
|
| 152 |
Treatment of advanced colorectal cancer with folinic acid and 5-fluorouracil in combination with cisplatinum
|
Sagaster, P.
|
|
1994
|
30 |
Supplement 1 |
p. 1250-1254
5 p.
|
artikel
|
| 153 |
Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous α-interferon
|
Besana, C.
|
|
1994
|
30 |
Supplement 1 |
p. 1292-1298
7 p.
|
artikel
|
| 154 |
Treatment of unresectable hepatocellular carcinoma with a combination of human recombinant α-2b interferon and doxorubicin: Results of a pilot study
|
Lotz, J.P.
|
|
1994
|
30 |
Supplement 1 |
p. 1319-1325
7 p.
|
artikel
|
| 155 |
Tumor cell kinetics and tumor vasculature in breast cancer
|
Haustermans, K.
|
|
1994
|
30 |
Supplement 1 |
p. S20-
1 p.
|
artikel
|
| 156 |
Tumor markers in lung cancer: Superiority of CYFRA21-1 to CEA and SCC-Ag
|
Nikliński, J.
|
|
1994
|
30 |
Supplement 1 |
p. S34-
1 p.
|
artikel
|
| 157 |
Tumour necrosis factor-α, interleukin-1β and interleukin-6 in patients with renal cell carcinoma
|
Dosquet, Christine
|
|
1994
|
30 |
Supplement 1 |
p. 162-167
6 p.
|
artikel
|
| 158 |
Unusual clonal evolution during blast crisis of chronic myeloid leukaemia (CML)
|
Christodoulidou, F.
|
|
1994
|
30 |
Supplement 1 |
p. 1040-1041
2 p.
|
artikel
|
| 159 |
VI. What has been achieved by primary and secondary prevention campaigns?
|
Mackie, R.
|
|
1994
|
30 |
Supplement 1 |
p. 558-560
3 p.
|
artikel
|
| 160 |
Weekly epirubicin in hormone-resistant metastatic breast cancer(MBC) in the elderly
|
Tucci, E.
|
|
1994
|
30 |
Supplement 1 |
p. S26-
1 p.
|
artikel
|
| 161 |
Why don't we use a “cavalieri”?
|
Bentzen, J.K.D.
|
|
1994
|
30 |
Supplement 1 |
p. 421-422
2 p.
|
artikel
|
| 162 |
Wide range for optimal concentration of folinic acid in fluorouracil modulation—Experimental data on human tumour cell lines
|
Beck, A.
|
|
1994
|
30 |
Supplement 1 |
p. 1522-1526
5 p.
|
artikel
|
Tijdschrift beschrijving